Creative Medical seeks US FDA orphan drug designation for ImmCelz platform to treat brittle type 1 diabetes
Creative Medical Technology Holdings, Inc., a biotechnology company working to revolutionize care through the development of potentially best-in-class regenerative therapeutics, announced that it filed an application with the US Food and Drug …